Business Context and Reporting Period
Quantum-Si Inc. (QSI) filed a Form 8-K Current Report on September 26, 2025. The filing discloses the entry into a Material Definitive Agreement to facilitate the potential sale of equity securities.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the terms of a new sales agreement.
Material Changes and Agreements
- Sales Agreement: On September 26, 2025, the Company entered into a Sales Agreement with Leerink Partners LLC.
- Offering Capacity: The Company may offer and sell up to $100,000,000 of its Class A common stock through Leerink Partners acting as sales agent or principal.
- Method of Sale: Sales may be conducted as "at the market" offerings under Rule 415(a)(4) of the Securities Act of 1933, subject to the Company's discretion and instructions regarding price, time, and size.
- Compensation: Leerink Partners is entitled to a commission of up to 3.0% of the gross offering proceeds per share sold.
- Expense Reimbursement: The Company agreed to reimburse Leerink Partners up to $75,000 for actual outside legal expenses incurred in connection with the agreement.
- Registration Status: The sale of shares is contingent upon the effectiveness of a shelf registration statement on Form S-3 filed on September 26, 2025. The Company provides no assurance that the registration statement will become effective.
Guidance, Outlook, and Risks
- Discretionary Nature: The Company has no obligation to sell any shares and may suspend offers or terminate the agreement at any time.
- Termination Rights: Either party may terminate the Sales Agreement at any time upon proper written notice.
- Regulatory Risk: The offering is subject to the effectiveness of the Form S-3 registration statement and applicable securities laws.
Investor Verification Checklist
- Verify the effectiveness status of the Form S-3 Registration Statement filed on September 26, 2025.
- Monitor future filings for actual share issuances and proceeds generated under the Sales Agreement.
- Review the full text of the Sales Agreement (Exhibit 1.1) for specific limitations on sales volume or pricing not detailed in the summary.
- Check for any subsequent amendments or terminations of the agreement with Leerink Partners.